These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 8105616)

  • 1. Modulation of eicosanoid formation by lesional skin of psoriasis: an ex vivo skin model.
    Fogh K; Iversen L; Herlin T; Kragballe K
    Acta Derm Venereol; 1993 Jun; 73(3):191-3. PubMed ID: 8105616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eicosanoids in acute and chronic psoriatic lesions: leukotriene B4, but not 12-hydroxy-eicosatetraenoic acid, is present in biologically active amounts in acute guttate lesions.
    Fogh K; Herlin T; Kragballe K
    J Invest Dermatol; 1989 Jun; 92(6):837-41. PubMed ID: 2542417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro inhibition of leukotriene B4 formation by exogeneous 5-lipoxygenase inhibitors is associated with enhanced generation of 15-hydroxy-eicosatetraenoic acid (15-HETE) by human neutrophils.
    Fogh K; Herlin T; Kragballe K
    Arch Dermatol Res; 1988; 280(7):430-6. PubMed ID: 2849922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective decrease of 15-hydroxyeicosatetraenoic acid (15-HETE) formation in uninvolved psoriatic dermis.
    Kragballe K; Duell EA; Voorhees JJ
    Arch Dermatol; 1986 Aug; 122(8):877-80. PubMed ID: 3090943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of lipoxygenase products in psoriatic skin homogenates by QA 208-199.
    Schnyder J; Hunziker T; Strasser M; Richardson B; Krebs A
    Arch Dermatol Res; 1986; 278(6):494-6. PubMed ID: 3024587
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro synthesis of 12-hydroxy-eicosatetraenoic acid is increased in uninvolved psoriatic epidermis.
    Kragballe K; Desjarlais L; Duell EA; Voorhees JJ
    J Invest Dermatol; 1986 Jul; 87(1):47-52. PubMed ID: 3088130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eicosanoids in skin of patients with atopic dermatitis: prostaglandin E2 and leukotriene B4 are present in biologically active concentrations.
    Fogh K; Herlin T; Kragballe K
    J Allergy Clin Immunol; 1989 Feb; 83(2 Pt 1):450-5. PubMed ID: 2537352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biosynthesis of lipoxygenase products by enzyme preparations from normal and psoriatic skin.
    Ziboh VA; Casebolt TL; Marcelo CL; Voorhees JJ
    J Invest Dermatol; 1984 Dec; 83(6):426-30. PubMed ID: 6094672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of 5,12, and 15-lipoxygenase products in keratomed biopsies of normal and psoriatic skin.
    Duell EA; Ellis CN; Voorhees JJ
    J Invest Dermatol; 1988 Nov; 91(5):446-50. PubMed ID: 2844912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of sulfasalazine and a sulfasalazine analogue on the formation of lipoxygenase and cyclooxygenase products.
    Tornhamre S; Edenius C; Smedegård G; Sjöquist B; Lindgren JA
    Eur J Pharmacol; 1989 Oct; 169(2-3):225-34. PubMed ID: 2572437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical steroid treatment reduces arachidonic acid and leukotriene B4 in lesional skin of psoriasis.
    Wong E; Barr RM; Cunningham FM; Mistry K; Woollard PM; Mallet AI; Greaves MW
    Br J Clin Pharmacol; 1986 Dec; 22(6):627-32. PubMed ID: 3032226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic and clinical effects of lonapalene (RS 43179), a 5-lipoxygenase inhibitor, in psoriasis.
    Black AK; Camp RD; Mallet AI; Cunningham FM; Hofbauer M; Greaves MW
    J Invest Dermatol; 1990 Jul; 95(1):50-4. PubMed ID: 2164070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eicosanoid production by human aortic endothelial cells in response to endothelin.
    Hollenberg SM; Tong W; Shelhamer JH; Lawrence M; Cunnion RE
    Am J Physiol; 1994 Dec; 267(6 Pt 2):H2290-6. PubMed ID: 7810729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 15-HETE is the main eicosanoid formed by human colonic mucosa.
    Zijlstra FJ; van Dijk AP; Wilson JH; van Riemsdijk-Overbeeke IC; Vincent JE; Ouwendijk RJ
    Agents Actions; 1992; Spec No():C53-9. PubMed ID: 1442336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal cell-polymorphonuclear leukocyte cooperation in the formation of leukotriene B4 by transcellular biosynthesis.
    Solá J; Godessart N; Vila L; Puig L; de Moragas JM
    J Invest Dermatol; 1992 Mar; 98(3):333-9. PubMed ID: 1312107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of eicosanoid formation in human polymorphonuclear leukocytes by high concentrations of magnesium ions.
    Ludwig P; Petrich K; Schewe T; Diezel W
    Biol Chem Hoppe Seyler; 1995 Dec; 376(12):739-44. PubMed ID: 9072050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arachidonic acid metabolism by rat alveolar epithelial cells.
    Chauncey JB; Peters-Golden M; Simon RH
    Lab Invest; 1988 Feb; 58(2):133-40. PubMed ID: 2828765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring eicosanoid biosynthesis via lipoxygenase and cyclooxygenase pathways in human whole blood by single HPLC run.
    Frohberg P; Drutkowski G; Wobst I
    J Pharm Biomed Anal; 2006 Jun; 41(4):1317-24. PubMed ID: 16621414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic eicosanoid responses upon different inhibitor and combination treatments on the arachidonic acid metabolic network.
    He C; Wu Y; Lai Y; Cai Z; Liu Y; Lai L
    Mol Biosyst; 2012 Apr; 8(5):1585-94. PubMed ID: 22446875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dihomogammalinolenic acid and its 15-lipoxygenase metabolite on eicosanoid metabolism by human mononuclear leukocytes in vitro: selective inhibition of the 5-lipoxygenase pathway.
    Iversen L; Fogh K; Kragballe K
    Arch Dermatol Res; 1992; 284(4):222-6. PubMed ID: 1329675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.